664P Impact of treatment beyond progression (TBP) in patients treated with immunotherapy (IO) in phase I trials (Ph1)
| Autor: | Lostes Bardaji, M.J., Mel Olano, A., Mirallas, O., Morchón Araujo, D., Pérez Fernandez, S., Raskina, K., Galvao, V., Alonso Casal, G., Oberoi, A., Pretelli, G., Rojas Laimito, K.I., Ortega Morillo, B., Ortiz Velez, C., Muñoz-Couselo, E., Viaplana, C., Vieito, M., Braña, I., Dienstmann, R., Hernando Calvo, A., Garralda, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S522-S522 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|